ABSTRACT.
To The ITLC was performed on silica-gel-impregnated glass fiber sheets (Gelman Sciences Inc., Ann Arbor, MI) with 0.5 M sodium citrate (pH = 4.5) as mobile phase. The TLC was performed on aluminum-backed cellulose plates (Merck, Darmstadt, Germany); n-butanol/water/acetic acid (2/1/l) was used as mobile phase. After elution, the plates were cut into 10 pieces and assayed for radioactivity using a 1282 Compugamma counter (Wallac, Turku, Finland) .
Gel filtration was performed on G-25 (PD-lo-columns) and G-50 using a 0.1 M acetate buffer (pH = 6) as eluent, unless described otherwise. The G-25 and G-50 gel filtration column materials were from Pharmacia Biotech (Roosendaal, The Netherlands).
High-performance liquid chromatography (HPLC) was performed on a Protein Pak 300 SW column (Waters, Milford, MA) using a Pharmacia HPLC-pump (2150). Ammonium acetate (0.2 M, pH = 6.5) containing 0.05% sodium azide was used as eluent (flow rate 0.5 mL/min). A UV-detector (Pharmacia, Uppsala, Sweden) at 280 nm and a flow-through radioactivity detector (Ortec 406A single-channel analyzer) were used to monitor the eluate.
"Direct
Labeling"
of Bovine Serum Albumin with "Zr (88Zr-BSA)
The s8Zr was isolated in oxalic acid with a hydroxamate-column as described by Meijs er al. (24) . The oxalic acid was removed by sublimation at room temperature in vacua. BSA (100 p.g) in 100 PL of either 0.1 M acetate buffer (pH = 5 and 6) or 0.1 M citrate buffer (pH = 5 and 6) was added to this freeze-dried Zr-oxalate. After 1 h of incubation the protein was analyzed by G-50 gel filtration and ITLC.
N-(S-acetyl)Mercuptoacetyldesferal
[SATA-Dfl SATA-Df (Scheme 1) was prepared by dissolving Df (0.473 mmol) in 10 mL of water. The pH was adjusted to 9 using 1 M NaOH. SATA (0.179 mmol) was added and the reaction mixture was allowed to stand at room temperature for 2 h. Hereafter, the solution was acidified to pH = 2 using concentrated HCl, resulting in precipitation of SATA-Df, while unreacted Df remained in the solution. Recrystallization from 10 mL of 1 mM HCl yielded 0.139 mmol SATA-Df (78%). The product was analyzed by TLC and mass spectrometry (Finnigan MAT90, Bremen, Germany). Silicaplates (DC Alufolien from Merck, Darmstadt, Germany) were used for the TLC analysis. Spots were eluted with MeOH and detected by spraying with 1% FeCl,; the product was found to have an Rf-value of 0.65, while Df remained at the origin. 
The number of maleimide groups in the protein (before reaction with SATA-Df) was determined chemically using Ellman's reagent. For this purpose, 50 p,L of mercaptoethanol(96.5 nmol) was added to 50 p,L of reaction mixture and diluted with 1.5 mL of phosphate buffer (0.1 M, pH = 8.5). Finally, 50 p-L of Ellman's reagent (4 mg/mL) was added. After 15 min of incubation at room temperature the UV-absorbance was measured at 4 12 nm. Standards of mercaptoethanol from 0 to 100 nmol were used for quantification. The protein concentration was determined using biorad protein assay (Munchen, Germany) with BSA solutions (O-O.5 mg/mL) as standards.
Molecular-weight measurements were performed by matrixassisted laser desorption ionization mass spectrometry (MALDI-MS) using a Finnigan MAT Vision 200 laser desorption time-offlight mass spectrometer (12).
Labeling of BSA-Df with 88Zr (88Zr-Df-BSA)
The BSA-Df in 100 p,L of acetate (0.1 M, pH = 6) was added to freeze-dried 88Zr-oxalate (aide supra). The reaction mixture was analyzed by gel filtration (G-25, G-50, and HPLC) and ITLC. To optimize the labeling, the conditions were varied and the reaction mixtures were analyzed with ITLC. The time dependency of the labeling efficiency between 5 min and 2 h was examined. The influence of the protein concentration was determined using BSADf at 3, 1, 0.5, 0.1, and 0.05 mg/mL. The labeling efficiency was determined after 1 h of incubation at room temperature.
In Vitro Stability Studies
The difference in stability of the protein-conjugate (0.42 mg/mL) obtained both by "direct" labeling or via Df was determined in citrate buffer of different concentrations (0.167, 1.67, 16.7,167, and 1670 mM).
The percentage of '*Zr attached to the protein was measured using gel filtration. (Fig. lb) .
For a better understanding of the in viva behavior of Zr-labeled proteins, we also examined the biodistribution of *'Zr-citrate and '*Zr-Df. The blood clearance of the '*Zr-compounds was dependent on the chemical form of the 88Zr (Fig. 4) . Zr-Df was cleared quickly from the circulation. After 5 min more than 23% of the injected dose was found in the urine. This fast glomerular excretion probably caused the temporary high kidney level. Uptake in other organs did not exceed 2% after 30 min (Table  1 ). The clearance of "Zr-citrate was slower than that of the Zr-Df complexes; after 4 and 24 h, 16.3 and 3.0 %lD/g, respectively, were still present in the blood. The Zr was finally deposited in bone (21 %lD/g at 24 h). The levels of Zr present in liver and kidney did not follow the clearance of the blood (Fig. 4) except for the uptake in liver, spleen, and kidneys, which was higher for 88Zr-13f-MSA. The amount of 88Zr in these organs remained the same over the time period measured, whereas the amount of 1231 decreased in time (Fig. 4) . At higher SMCC/MSA ratio, the liver accumulation is higher and the kidney accumulation is lower (Fig. 6) 
